{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:43Z","timestamp":1786975603027,"version":"build-2736575974"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamainternmed.2021.8515","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T11:39:41Z","timestamp":1645443581000},"page":"376","source":"Crossref","is-referenced-by-count":83,"title":["Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines"],"prefix":"10.1001","volume":"182","author":[{"given":"Derek K.","family":"Chu","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"The Research Institute of St Joe\u2019s Hamilton, Hamilton, Ontario, Canada"},{"name":"Evidence in Allergy Group, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology, Department of Pediatrics and Child Health, The University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B. K.","family":"Golden","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Wolfson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Cosby A.","family":"Stone","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Krantz","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Shaker","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire"},{"name":"Dartmouth Geisel School of Medicine, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[{"name":"Food Challenge and Research Unit, Section of Allergy and Clinical Immunology, Children\u2019s Hospital Colorado, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"ioi210091r2","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach.","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"ioi210091r4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine\u2014United States, December 21, 2020-January 10, 2021.","volume":"70","author":"CDC COVID-19 Response Team","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"ioi210091r6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update.","volume":"130","author":"Kelso","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"31","key":"ioi210091r7","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"17","key":"ioi210091r8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/BF01716961","article-title":"Incidence and classification of adverse reactions to plasma substitutes.","volume":"60","author":"Ring","year":"1982","journal-title":"Klin Wochenschr"},{"issue":"10","key":"ioi210091r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization anaphylaxis guidance 2020.","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"2","key":"ioi210091r10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium.","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"ioi210091r11","doi-asserted-by":"publisher","first-page":"h870","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients.","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"issue":"12","key":"ioi210091r12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7, rating the quality of evidence\u2014inconsistency.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"ioi210091r14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab507","article-title":"Graded administration of second dose of Moderna and Pfizer-BioNTech COVID-19 mRNA vaccines in patients with hypersensitivity to first dose.","volume":"8","author":"Tuong","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"ioi210091r15","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1111\/all.v76.9","article-title":"Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: don\u2019t give up on the second dose!","volume":"76","author":"Krantz","year":"2021","journal-title":"Allergy"},{"issue":"5","key":"ioi210091r16","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12044","article-title":"Patients with suspected allergic reactions to COVID-19 vaccines can be safely revaccinated after diagnostic work-up.","volume":"11","author":"Rasmussen","year":"2021","journal-title":"Clin Transl Allergy"},{"issue":"11","key":"ioi210091r17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/jamainternmed.2021.3779","article-title":"Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose.","volume":"181","author":"Krantz","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"9","key":"ioi210091r18","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1016\/j.jaip.2021.06.010","article-title":"First-dose mRNA COVID-19 vaccine allergic reactions: limited role for excipient skin testing.","volume":"9","author":"Wolfson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"ioi210091r19","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1111\/all.v76.11","article-title":"Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose.","volume":"76","author":"Kessel","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"ioi210091r20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.anai.2021.03.024","article-title":"Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines.","volume":"127","author":"Kelso","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"ioi210091r21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.7326\/L21-0104","article-title":"Administration of a second dose of the Moderna COVID-19 vaccine after an immediate hypersensitivity reaction with the first dose: two case reports.","volume":"174","author":"Mustafa","year":"2021","journal-title":"Ann Intern Med"},{"key":"ioi210091r22","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab448","article-title":"Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration.","author":"Vanijcharoenkarn","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ioi210091r23","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1016\/j.jaip.2021.05.031","article-title":"Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination.","volume":"9","author":"Robinson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ioi210091r24","article-title":"Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction.","author":"Eastman","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ioi210091r25","doi-asserted-by":"crossref","DOI":"10.1093\/milmed\/usab138","article-title":"Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria.","author":"Park","year":"2021","journal-title":"Mil Med"},{"issue":"5","key":"ioi210091r26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2500\/aap.2021.42.210069","article-title":"Allergic reactions and adverse events associated with administration of mRNA-based vaccines: a health-care system experience.","volume":"42","author":"Arroliga","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"ioi210091r27","first-page":"0","article-title":"Allergic reactions after administration of Pfizer-BioNTech COVID-19 vaccine to healthcare workers at a tertiary hospital.","volume":"0","author":"Loli-Ausejo","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"6","key":"ioi210091r28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.anai.2021.03.012","article-title":"Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: early report.","volume":"126","author":"Pitlick","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"44","key":"ioi210091r29","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1016\/j.vaccine.2021.09.048","article-title":"Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.","volume":"39","author":"Yacoub","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"ioi210091r30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk.","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ioi210091r31","article-title":"Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing.","author":"Kohli-Pamnani","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"ioi210091r33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system.","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ioi210091r34","article-title":"Polyethylene glycol and polysorbate testing in 12 patients before or after coronavirus disease 2019 vaccine administration.","author":"Carpenter","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ioi210091r35","article-title":"Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.","author":"Kaplan","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"ioi210091r37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaci.2021.01.003","article-title":"Severity grading system for acute allergic reactions: a multidisciplinary Delphi study.","volume":"148","author":"Dribin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"ioi210091r1","unstructured":"Johns Hopkins University Coronavirus Resource Center. COVID-19 map. Accessed September 28, 2021. https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"ioi210091r3","unstructured":"Medicines and Healthcare Products Regulatory Agency. Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer\/BioNTech vaccine. Accessed December 15, 2020. https:\/\/www.gov.uk\/government\/news\/confirmation-of-guidance-to-vaccination-centres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine?"},{"key":"ioi210091r5","unstructured":"Centers for Disease Control and Prevention. What to do if you had an allergic reaction after getting a COVID-19 vaccine. Accessed September 20, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/allergic-reaction.html?"},{"key":"ioi210091r13","unstructured":"The University of Adelaide, JBI. Critical appraisal tools. Accessed September 1, 2021. https:\/\/jbi.global\/critical-appraisal-tools"},{"key":"ioi210091r32","doi-asserted-by":"crossref","unstructured":"Inoue? S, Igarashi? A, Morikane? K, . Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy.? medRxiv. Preprint posted September 16, 2021. doi:10.1101\/2021.09.13.21263473","DOI":"10.1101\/2021.09.13.21263473"},{"key":"ioi210091r36","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. Accessed January 26, 2021. https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html?"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2788991\/jamainternal_chu_2022_oi_210091_1648847683.59199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:04:59Z","timestamp":1649070299000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2788991"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2021.8515","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}